Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
151
datasets available to search
ShareScore release 0.9.0
Dataset results
151 results for “Protein vaccines”
Immuno-bridging Study of COVID-19 Protein Subunit Recombinant Vaccine
ClinicalTrials.gov study NCT05433285. IPD Sharing: NO. Countries: 1. Publications: 1.
A Phase 3b/4 Randomised Trial of 3 Doses of Protein-based Covid-19 Vaccine (SpikoGen)
ClinicalTrials.gov study NCT05279456. IPD Sharing: NO. Countries: 1. Publications: 1.
Study on Heterologous Prime-boost of Recombinant COVID-19 Vaccine (Ad5 Vector) and RBD-based Protein Subunit Vaccine
ClinicalTrials.gov study NCT04833101. IPD Sharing: YES. Countries: 1. Publications: 1.
Omicron BA.4/5-Delta Strain Recombinant Novel Coronavirus Protein Vaccine (CHO Cells)
ClinicalTrials.gov study NCT05850507. IPD Sharing: Not stated. Countries: 1. Publications: 2.
Recombinant SARS-CoV-2 Fusion Protein Vaccine (V-01) Booster Study
ClinicalTrials.gov study NCT05096832. IPD Sharing: Not stated. Countries: 2. Publications: 1.
A Study Assessing the Safety, Tolerability, Immunogenicity of COVID-19 Vaccine Candidate PRIME-2-CoV_Beta, Orf Virus Expressing SARS-CoV_2 Spike and Nucleocapsid Proteins
ClinicalTrials.gov study NCT05367843. IPD Sharing: Not stated. Countries: 2. Publications: 1.
Concomitant Use of Hepatitis A Vaccine, Inactivated With Haemophilus b Conjugate Vaccine (Meningococcal Protein Conjugate) and Diphtheria and Tetanus Toxoids and Acellular Pertussis Vaccine Adsorbed G
ClinicalTrials.gov study NCT00289913. IPD Sharing: YES. Countries: 0. Publications: 1.
Immunogenicity and Safety of a Booster Vaccination With a Recombinant Protein RBD Candidate Vaccine Against SARS-CoV-2 in Healthy Adults Volunteers Fully Vaccinated Followed by an Extension Period to
ClinicalTrials.gov study NCT05142553. IPD Sharing: NO. Countries: 1. Publications: 3.
Anti-COVID19 AKS-452 Fusion Protein Vaccine - ACT Study
ClinicalTrials.gov study NCT04681092. IPD Sharing: NO. Countries: 1. Publications: 2.
The Immune Response of Heterologous Boost Third Dose of mRNA and Protein COVID-19 Vaccine
ClinicalTrials.gov study NCT05132855. IPD Sharing: NO. Countries: 1. Publications: 4.
Safety and Immunogenicity of a Quadrivalent Meningococcal Tetanus Protein Conjugate Vaccine in Toddlers
ClinicalTrials.gov study NCT00631995. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Evaluation on Seropositive Patients of a Synthetic Vaccine Targeting the HIV Tat Protein
ClinicalTrials.gov study NCT01793818. IPD Sharing: YES. Countries: 1. Publications: 1.
A Clinical Trial to Evaluate the Safety and Immunogenicity of Recombinant HIV-1 Envelope Protein BG505 SOSIP.GT1.1 Gp140 Vaccine, Adjuvanted in Healthy, HIV-uninfected Adults
ClinicalTrials.gov study NCT04224701. IPD Sharing: Not stated. Countries: 2. Publications: 1.
A Controlled Phase 2/3 Study of Adjuvanted Recombinant SARS-CoV-2 Trimeric S-protein Vaccine (SCB-2019) for the Prevention of COVID-19
ClinicalTrials.gov study NCT04672395. IPD Sharing: Not stated. Countries: 5. Publications: 10.
Phase I Clinical Trial of Recombinant SARS-CoV-2 Spike Protein Vaccine (CHO Cell) for the Prevention of COVID-19
ClinicalTrials.gov study NCT04982068. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Evaluation of the Protective Efficacy of a Vaccine Derived From the Synthetic CS Protein of Plasmodium Vivax
ClinicalTrials.gov study NCT02083068. IPD Sharing: Not stated. Countries: 1. Publications: 2.
Safety, Efficacy, Immunogenicity Study of GSK Biologicals' HBV Viral Vector and Adjuvanted Proteins Vaccine (GSK3528869A) in Adult Patients With Chronic Hepatitis B Infection
ClinicalTrials.gov study NCT03866187. IPD Sharing: YES. Countries: 9. Publications: 0.
Evaluating HIV-1 Neutralization Antibody Breadth in Response to HIV gp120 Protein Vaccine in HIV-uninfected Adults With Quiescent Systemic Lupus Erythematosus
ClinicalTrials.gov study NCT03618056. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Phase 1 Clinical Trial to Evaluate the Safety and Immunogenicity of HIV-1 Chimp Adenovirus Vaccines Expressing Clade C gp140 & CH505TF gp120 Protein Boost in HIV-uninfected Adult.
ClinicalTrials.gov study NCT05182125. IPD Sharing: Not stated. Countries: 1. Publications: 0.
CORVax12: SARS-CoV-2 Spike (S) Protein Plasmid DNA Vaccine Trial for COVID-19 (SARS-CoV-2)
ClinicalTrials.gov study NCT04627675. IPD Sharing: NO. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.